After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will no longer advertise compounded GLP-1 drugs, the company announced Monday. Instead, ...
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign. The blockbuster drug Humira has been one of the world's top sellers for ...
Eli Lilly & Co. sent a wave of letters to U.S. health care providers in recent days demanding they stop promoting copycat weight-loss drugs as supply of the company's brand-name medicines improves.
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign. Copycat drugs could end Humira's reign as the prominent arthritis ...
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results